For the quarter ending 2025-09-26, STAA had $9,024K increase in cash & cash equivalents over the period. $1,784K in free cash flow.
| Cash Flow | 2025-09-26 | 2025-06-27 |
|---|---|---|
| Net income (loss) | 8,884 | -71,023 |
| Depreciation of property, plant, and equipment | 2,000 | 4,312 |
| Non-cash operating lease expense | 799 | 1,866 |
| Impairment of fixed assets and operating lease right-of-use assets | 0 | 14,593 |
| Accretion/amortization of investments available for sale | 84 | -139 |
| Deferred income taxes | 9,906 | -10,624 |
| Change in net pension liability | 45 | -2 |
| Loss on disposal of property and equipment | -23 | - |
| Stock-based compensation expense | 8,158 | 13,817 |
| Provision for sales returns and credit losses | 2,793 | -1,818 |
| Inventory provision | 762 | 2,499 |
| Accounts receivable | 25,855 | -43,859 |
| Inventories | 1,244 | 11,205 |
| Prepayments, deposits, and other assets | 3,445 | 6,264 |
| Accounts payable | -2,487 | -5,424 |
| Other current and non-current liabilities | 2,244 | -7,430 |
| Net cash provided by (used in) operating activities | 2,667 | -32,983 |
| Acquisition of property and equipment | 883 | 3,260 |
| Purchase of investments available for sale | 11,773 | 14,691 |
| Proceeds from maturity of investments available for sale | 15,424 | 77,560 |
| Proceeds from sale of debt securities, available-for-sale | 2,515 | 862 |
| Net cash provided by (used in) investing activities | 5,283 | 60,471 |
| Repayment of finance lease obligations | 0 | 42 |
| Repurchase of common stock | 1,982 | 4,479 |
| Repurchase of employee common stock for taxes withheld | 0 | 1,356 |
| Proceeds from the exercise of stock options | 2,964 | 387 |
| Proceeds from vested restricted and performance stock units | 1 | 2 |
| Net cash provided by (used in) financing activities | 983 | -5,488 |
| Effect of exchange rate changes on cash and cash equivalents | 91 | 972 |
| Increase (decrease) in cash and cash equivalents | 9,024 | 22,972 |
| Cash and cash equivalents at beginning of period | 144,159 | - |
| Cash and cash equivalents at end of period | 176,155 | - |
STAAR SURGICAL CO (STAA)
STAAR SURGICAL CO (STAA)